CCIA
PPH icon

Cherry Creek Investment Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cherry Creek Investment Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$576K Sell
5,266
-8,558
-62% -$886K 0.23% 68
2026
Q1 		$1.44M Buy
13,824
+695
+5% +$74K 0.62% 36
2025
Q4 		$1.35M Buy
+13,129
New +$1.28M 0.58% 37

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Cherry Creek Investment Advisors's PPH Position: Q2 2026 in Review

Cherry Creek Investment Advisors reduced its VanEck Pharmaceutical ETF (PPH) stake by 62% in Q2 2026, selling an estimated $886K and leaving 5,266 shares worth $576K. The position accounts for 0.23% of the portfolio, ranked #68.

Cherry Creek Investment Advisors first reported a position in PPH in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.44M in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Cherry Creek Investment Advisors held 5,266 shares of VanEck Pharmaceutical ETF worth $576K as of Q2 2026.
  • Cherry Creek Investment Advisors sold 8,558 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $886K.
  • VanEck Pharmaceutical ETF made up 0.23% of Cherry Creek Investment Advisors's portfolio in Q2 2026, its #68 holding.
  • Cherry Creek Investment Advisors first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and has held it in 3 quarters since.
  • Cherry Creek Investment Advisors's VanEck Pharmaceutical ETF position peaked at $1.44M in Q1 2026.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Cherry Creek Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.